• About us
• Contact

Advertisement

Person › Details

Rogier Rooswinkel (Forbion Capital Partners (NL))

Rooswinkel, Rogier (Forbion 202004 Partner)

 

	Organisation	Forbion Capital Partners (NL)
	Group	Forbion (Group)
	Product	venture capital
	Product 2	LIFE SCIENCES

Record changed: 2024-10-04

Advertisement

More documents for Rogier Rooswinkel

• [1] LoQus23 Therapeutics Ltd.. (10/2/24). "Press Release: LoQus23 Therapeutics Announces £35 Million (c.$43 Million) Series A Financing to Advance Its Small Molecule Somatic Expansion Inhibition Therapy for Huntington’s Disease". Cambridge....
• [2] Amphista Therapeutics Ltd.. (3/17/21). "Press Release: Amphista Therapeutics Raises $53M in Oversubscribed Series B Round to Advance Next Generation Targeted Protein Degradation Assets". Glasgow....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.